(Q45923646)

17 December 2017

title

Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation. (English)

1 reference

17 December 2017

0 references

4

1 reference

17 December 2017

author name string

I Waern

series ordinal

1

1 reference

17 December 2017

A Lundequist

series ordinal

2

1 reference

17 December 2017

G Pejler

series ordinal

3

1 reference

17 December 2017

publication date

12 December 2012

1 reference

17 December 2017

published in

Mucosal Immunology

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

911-920

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/mi.2012.129

exact match

0 references

cites work

IgE and mast cells in allergic disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Biological implications of preformed mast cell mediators

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Mast cell proteases: multifaceted regulators of inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Mouse mast cell protease 4 is the major chymase in murine airways and has a protective role in allergic airway inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Animal models of asthma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

No audible wheezing: nuggets and conundrums from mouse asthma models

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

The development of allergic inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Inhaled house dust mite induces pulmonary T helper 2 cytokine production

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Mast cells can promote the development of multiple features of chronic asthma in mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Mast-cell infiltration of airway smooth muscle in asthma.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Mast cells limit extracellular levels of IL-13 via a serglycin proteoglycan-serine protease axis.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

The αvβ6 integrin modulates airway hyperresponsiveness in mice by regulating intraepithelial mast cells.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Relationship of small airway chymase-positive mast cells and lung function in severe asthma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Novel site-specific mast cell subpopulations in the human lung

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Activation of Mast Cells Is Essential for Development of House Dust Mite Dermatophagoides farinae-Induced Allergic Airway Inflammation in Mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

IL-33 exacerbates eosinophil-mediated airway inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

The cytokine interleukin-33 mediates anaphylactic shock

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Accumulation of Ym1 and formation of intracellular crystalline bodies in alveolar macrophages lacking heparanase

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Serglycin: the master of the mast cell

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Prostaglandin E(2) exerts homeostatic regulation of pulmonary vascular remodeling in allergic airway inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.129

7 January 2021

Identifiers

DOI

10.1038/MI.2012.129

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017